Allspring Global Investments Holdings, LLC Oncternal Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $59.3 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022
SELL
$0.7 - $1.56 $45,515 - $101,434
-65,022 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$1.37 - $2.43 $104,385 - $185,151
-76,194 Reduced 53.96%
65,022 $90,000
Q4 2021

Jan 28, 2022
BUY
$2.27 - $4.39 $320,560 - $619,938
141,216 New
141,216 $320,000

Others Institutions Holding ONCT

# of Institutions
3
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $29.4M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email